Green synthesis and characterization of silver nanoparticles using Vitex leucoxylon extracts: Analysis of anti-inflammatory activity
Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/67108
metadata.dc.identifier.doi:
https://doi.org/10.56042/ijeb.v63i11.20261Title: Green synthesis and characterization of silver nanoparticles using Vitex leucoxylon extracts: Analysis of anti-inflammatory activityAuthors:
Sravanthi M, VishnuS, NirmalaKeywords: Phytochemical capping agents;Cyclooxygenase-2 inhibition;Nitric oxide suppression;Molecular docking proxy model;RAW 264.7 macrophagesIssue Date: Nov-2025Publisher: NIScPR - CSIRAbstract: In this investigation, silver nanoparticles (AgNPs) were synthesised through an eco-friendly approach using aqueous leaf
extracts of Vitex leucoxylon, and their anti-inflammatory activity was examined in vitro. The resulting nanoparticles
underwent thorough physicochemical characterization employing UV–Vis spectrometry, FTIR, scanning electron
microscopy, X-ray diffraction, and dynamic light scattering. A sharp absorbance near 400 nm in the UV–Vis spectrum
verified successful nanoparticle formation. FTIR analysis suggested that bioactive plant compounds played a crucial role in
reducing and stabilizing the silver ions. Microscopy revealed that the particles were predominantly spherical with moderate
uniformity, while crystallinity was affirmed by XRD. The particles ranged in size from approximately 10 to 80 nm, and DLS
analysis revealed a dual-modal distribution with peaks around 75.9 nm and 274.5 nm, along with a zeta potential of
–1.3 mV. The anti-inflammatory efficacy was validated using LPS-stimulated RAW 264.7 macrophages in MTT and nitric
oxide assays, showing that AgNPs enhanced cell survival and reduced nitric oxide production more effectively than the
crude extract. Molecular docking studies further revealed a strong interaction between AgNPs and the COX-2 enzyme, with
a binding score of –8.2 kcal/mol. These results suggest that Vitex leucoxylon-based AgNPs hold promise as bioactive agents
in anti-inflammatory therapy.Page(s): 913-927ISSN: 0975-1009 (Online) ; 0019-5189 (Print)Appears in Collections:
IJEB Vol.63(11) [November 2025]Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.
Comments (0)